
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ATAD5 CRISPR/Cas9 KO Plasmid (h) | sc-405654 | 20 µg | $397.00 |
ATAD5 (ATPase family AAA domain-containing protein 5) is a genome stability factor that associates with the RFC-like complex and promotes unloading of PCNA from chromatin during DNA replication and post-replicative repair. By regulating PCNA dynamics, ATAD5 supports replication fork progression, limits replication stress, and contributes to DNA damage response signaling and sister chromatid cohesion. Loss or reduced function of ATAD5 perturbs replication-coupled repair pathways, elevates genomic instability, and has been linked to cancer susceptibility and broader DNA repair–related disease mechanisms. Its role at the interface of replication and repair makes ATAD5 a useful node for dissecting pathways that preserve chromosome integrity.
ATAD5 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ATAD5 gene in human cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the ATAD5 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, ATAD5 HDR Plasmid (h) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined ATAD5 target site.
When co-transfected with ATAD5 CRISPR/Cas9 KO Plasmid (h):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the ATAD5 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.